CURRENT GRANTS
VACCINE
$7,425,306
SYSTEM BIOLOGICAL ANALYSES OF INNATE
AND ADAPTIVE RESPONSES
TO VACCINATION
AND ADAPTIVE RESPONSES
TO VACCINATION
Duration: 07/013/2021-06/30/2021
Type: U19
Source: NIH/NIAID
Type: U19
Source: NIH/NIAID
$7,425,306
$257,357
VACCINE INDUCED IMMUNITY IN THE YOUNG
AND AGED-CORE B: SINGLE CELL
AND INTEGRATIVE GENOMICS CORE
AND AGED-CORE B: SINGLE CELL
AND INTEGRATIVE GENOMICS CORE
Duration: 4/30/2019-4/30/24
Type: U19
Source: NIAID
Type: U19
Source: NIAID
$257,357
HIV
$406,549
DEVELOPMENT OF MULTI-MODAL SINGLE-CELL
TECHNOLOGY TO DISSECT
EPITOPE SPECIFICITY TO HIV
TECHNOLOGY TO DISSECT
EPITOPE SPECIFICITY TO HIV
Duration: 6/26/15-5/31/25
Type: U24
Source: NIH/NIAD
Type: U24
Source: NIH/NIAD
$406,549
$573,342
POPULATION GENOTYPING OF THE GERMLINE
IMMUNOGLOBULIN
REPETOIRE IN AIDS-DESIGNATED RHESUS MACAQUES BREEDING COLONIES
IMMUNOGLOBULIN
REPETOIRE IN AIDS-DESIGNATED RHESUS MACAQUES BREEDING COLONIES
Duration: 5/21/2021-4/30/2025
Type: R24
Source: NIH/NIAID
Type: R24
Source: NIH/NIAID
$573,342
$522,280
BLOCKING TYPE 1 INTERFERON SIGNALING
IN REVERSE T CELL EXHAUSTION
AND CONTROL HIV-1 RESERVOIRS
IN REVERSE T CELL EXHAUSTION
AND CONTROL HIV-1 RESERVOIRS
Duration: 07/01/2018-06/03/2023
Type: R01
Source: NIH/NIAID
Type: R01
Source: NIH/NIAID
$522,280
$250,000
B AND T CELL BIOLOGY OF PROTECTION FROM AND
ERADICATION OF SIV/SHIV INFECTION
ERADICATION OF SIV/SHIV INFECTION
Duration: 4/1/16-3/31/22
Type: UM1
Source:NIH/NIAID
Type: UM1
Source:NIH/NIAID
$250,000
COVID-19
$3,186,999
WASTEWATER-BASED COVID-19 SURVEILLANCE
(RADx)
(RADx)
Duration: 04/16/2021-04/15/2022
Source: Ceres Nanosciences (NIH Prime)
Source: Ceres Nanosciences (NIH Prime)
$3,186,999